July 2015 Newsletter
16th World Conference on Lung Cancer is 38 Days Away - The World Conference on Lung Cancer (WCLC) is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. More than 7,000 delegates come from more than 100 countries to discuss the latest developments in thoracic malignancy research. Attendees include surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses, allied health professionals, advocates and patients. View Details
Kool & The Gang to Headline WCLC 2015 Gala Dinner
Fun Walk – Pancake Breakfast at the World Conference on Lung Cancer
GAIN Programs - United States Locations
16th Annual Targeted Therapies of Lung Cancer Meeting
Workshop in Lung Cancer Clinical Research in the LATAM region
IASLC ELECTION RESULTS
Please join us in congratulating our new President-Elect and our new Board of Directors:
Please join us in congratulating the winners of the 2015-2016 IASLC Lung Cancer Fellowship and Young Investigator Awards:
Dr. Fred R. Hirsch, CEO of IASLC, is delivering the Eighth Annual Addario Foundation Keynote Lecture at the 16th Annual International Lung Cancer Congress. The title of his address is: "Looking Into the Future of Lung Cancer Research." During the conference, Dr. Hirsch will also discuss "Biomarker Development for Immune Checkpoint Inhibitor Therapy" and participate in a case-based panel discussion on "The Future of Immunotherapy." View Details.
The LUNGevity Foundation named WCLC 2015 presenter Janet Freeman-Daily, a stage IV lung cancer survivor, its LUNGevity Hero for July. Janet will be part of a mini symposium at WCLC 2015. She will discuss Advocacy in Practice on Wednesday, July 9 at 2:15 p.m. in Room 703. Read more about the award.
August 2015: The International Association for the Study of Lung Cancer (IASLC) and the Journal of Thoracic Oncology (JTO) are pleased to present this feature each month to highlight certain articles of interest. The selected articles each month will be made available to the public for a limited time at the time of print. The articles below from the August issue of JTO are free for three months. Please share with your colleagues around the globe!
Alex A. Adjei, MD, PhD
The articles highlighted in the August issue of the Journal of Thoracic Oncology address different aspects of lung cancer and remind us of the complexity of this disease.
Invasive mucinous adenocarcinoma of the lung is a rare subtype. Shim et al have evaluated the genetic profile of 72 of these tumors, and have described their clinical characteristics as well, in “Unique genetic and survival characteristics of invasive mucinous adenocarcinoma of the lung.” There is an excellent accompanying editorial by Davies et al.: Rearranging Detection of Gene Rearrangements.
Total Lesion Glycolysis in Positron Emission Tomography Can Predict Gefitinib Outcomes in Non–Small-Cell Lung Cancer with Activating EGFR Mutation
Keam et al. used whole-body 18F-2-fluoro-2-deoxyglucose positron emission tomography/ computed tomography scans in 75 patients with NSCLC tumors harboring EGFR mutations and receiving first-line gefitinib, to create a predictive algorithm for clinical response. This article also has an excellent accompanying editorial: FDG-PET/CT as a Predictor of Outcome in EGFR-Mutant Non–Small-Cell Lung Cancer.
Patterns of Disease Recurrence after SABR for Early Stage Non–Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy
Verstegen et al report on the incidence and salvage of local recurrences and second primary lung cancers in 855 patients treated with stereotactic ablative radiotherapy. These patients had a long follow up with a median of 52 months, and the authors have generated data for evidence- based follow-up regimens.
It is with pleasure that we announce a new joint introductory membership between the IASLC and the British Thoracic Oncology Group (BTOG). In recognition of many years of collaboration, there is now a special offer available to members of BTOG, who are new to the IASLC, to join IASLC for a special discounted rate of $125 for 1-year, and $475 for 3-years. Members joining with this special rate will be full members of the society. (*Note: The only exception is the 1-year option is a non-voting membership.) For more details about this special offer, please visit https://www.iaslc.org/btog-membership-offer.
BTOG is a UK lung cancer and mesothelioma research group. BTOG aims to improve the care of patients with thoracic malignancies through multidisciplinary education, developing and advising on guidelines for patient care and facilitating and nurturing clinical trial ideas into full protocols.
BTOG represents all the disciplines involved in the care of lung cancer and mesothelioma throughout the UK and includes medical and clinical oncologists, respiratory physicians, surgeons, radiotherapists, radiologists, nurses, pharmacists and scientists. All individuals involved in any aspect of lung cancer or mesothelioma research, care or treatment are eligible to become members of the Group.
BTOG hosts continuing medical education events through the UK and Ireland, including the Annual Conference. In 2016, the BTOG annual conference will be held in Dublin on January 27-29, 2016. As previous years, this meeting has been an endorsed event by the IASLC. With over 720 attendees and 190 posters in 2015, 2016 is sure to be a successful event. In September of 2015, BTOG will also host a Study Day, on the topic of “The Burden of Bone Disease in Lung Cancer”. Registration is free for healthcare providers involved in Thoracic Oncology. Other notable future educational events in this region include the International Mesothelioma Interest Group 2016 Meeting May 1-4, 2016, and the UK National Lung Cancer Forum for Nurses Annual Meeting November 19-20, 2015.
Additional news from the UK and Ireland includes the announcement of the 2015 BTOG Lifetime Achievement Award, which goes to Fergus MacBeth, FRCP,MA,MBA,DM,FRCR, of the Wales Cancer Trials Unit, Cardiff. Dr. Macbeth is also a has been a dedicated IASLC Member for more than 20 years. The photo attached shows (from left): Dr. Jason Lester, Consultant in Oncology, Velindre Hospital, Wales (Presenter of the Award); Dr. Fergus Macbeth (Award winner); Dr. Sanjay Popat (BTOG Chair).
Invite Your Colleagues to Join IASLC!
Thanks for your membership in IASLC and your support in growing our global team! Invite a Colleague Now
COMPLIMENTARY Fellows/Residents/Students/Trainees Membership – Group Program Registration
World Lung Cancer Awareness Day 2015
WCLC 2015: Free Attendance for Patients/Survivors!
Over this life changing weekend, survivors, patients, caregivers, advocates and healthcare professionals will learn how to bring the lung cancer movement to their communities. This year’s Summit is being held in the gorgeous NYC Metro Area from 9/17-9/20. The three days of interactive training sessions will teach you how to inspire change, educate others, and boost your advocacy impact! Learn More
12th International Conference of Asian Clinical Oncology Society (ACOS)
Many cancers are preventable, many are curable and rest are treatable. Asia is the largest continent, houses 60% of world population and has major cancer burden. Asian countries share challenges in terms of cancer types, therefore there is a greater need to collaborate and address the gaps to have better cure and care of cancer patients. Therefore the theme of conference is “Cancer in Asia: Bridging the Gaps”.
The objectives of ACOS includes cancer prevention, epidemiology, statistics, multidisciplinary treatment i.e. surgery, chemotherapy including oriental medicine, radiotherapy, as well as patient care under high grade development of translational research.
The ACOS is the Biennial International Conference, held in one of our various member countries in Asia. Our aim is foster cancer research & treatment in Asia, clinical experience sharing and enhancing professional networks resulting in advancements of data collation and publication to address the needs of oncologists and cancer patients in Asia. Details
Become a Member
Join the only international association solely dedicated to lung cancer research and treatment.
WCLC Virtual Library
November 17 2018San Francisco, California
February 20 - 23 2019Santa Monica, California
April 3 - 5 2019New York, New York